The federal fraud case against the top executives of the failed biotech company Theranos posed an interesting tale of two different trials. 'The Dropout' host RebeccaJarvis breaks it down:
The company claimed it could run any blood test using only a few drops of blood via its so-called proprietary technology. However, according to prosecutors, their product, a machine called "Edison," could never run more than a dozen blood tests at a time.
"[The abuse claims] did not come up at his trial, but for during [Holmes'] seven days of testimony, they were a big portion of what she talked about," Jarvis told "Start Here." "You can imagine where the jury may have found that presentation more sympathetic than Sunny Balwani who had experience," she said.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Sunny Balwani trial update: Former Theranos President found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Les mer »
Sunny Balwani trial update: Former Theranos President found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Les mer »
Sunny Balwani trial update: Former Theranos president found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Les mer »
Former Theranos COO Sunny Balwani Found Guilty on 12 Counts in FraudElizabeth Holmes’ ex-boyfriend and Theranos’ former COO Sunny Balwani has been convicted of fraud.
Les mer »
Theranos Ex-CEO Sunny Balwani Found Guilty in All 12 Fraud Charges 6 Months After Founder Holmes' ConvictionThe jury in former Theranos executive Ramesh “Sunny” Balwani reached a verdict on Thursday.
Les mer »
Former Theranos executive Sunny Balwani convicted in criminal fraud caseBREAKING: Former Theranos president Ramesh “Sunny” Balwani found guilty of defrauding investors and patients in connection with his blood-testing startup.
Les mer »